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Abstract: 
Hemophagocytic lymphohistiocytosis (HLH) is an uncommon cytokine storm 
syndrome marked by high mortality.  In adults, acquired HLH usually has an 
underlying infectious, autoimmune or malignant process that triggers the 
syndrome. In this case report, we present a 64-year old Caucasian male presenting 
with productive cough, fevers, weight loss and altered mental status who was 
ultimately found to have HLH of unknown etiology. 
 
Introduction:  
According to the 2008 diagnostic criteria, HLH is established by a molecular 
diagnosis of pathologic mutation or through clinical and laboratory findings of fever, 
splenomegaly, cytopenias, hypertriglyceridemia and/or hypofibrinogenemia, tissue 
diagnosis of hemophagoyctosis in the bone marrow, spleen or lymph nodes, low or 
absent natural killer cell activity, elevated ferritin (>500 ng/ mL), and soluble CD 25 
> 2400 U/mL. As a cytokine storm syndrome, HLH is often confused for sepsis, 
macrophage-activation syndrome (MAS) and other multi-organ system failures. 
Early recognition of HLH can prompt timely treatment and improve morbidity and 
mortality. Current therapeutic options include immunosuppression, immune 
modulation, chemotherapy, and biological response modification followed by bone 
marrow transplant. 
 
Case Report:  
A 64-year old Caucasian gentleman presented to the Emergency Department with 
complaints of lethargy, weakness, progressive dyspnea on exertion, productive 
cough of whitish sputum and a fever of 102.5 F. His past medical history was 
significant for non-insulin dependent diabetes, CAD s/p stent 14 years prior, 
hypertension, and atrial fibrillation.  He had a 14 pack year smoking history and had 
quit smoking 13 years prior. On review of systems, he admitted to a 5 lbs weight 
loss over the past 3 months, intermittent bouts of confusion and recent leg swelling. 
Deep venous thrombosis was excluded by his primary care physician, a week prior 
to admission. While in the ED, a CBC showed pancytopenia, marked by a white blood 
cell count of 2.7 and anemia with hemoglobin of 10.1.  A CXR was performed 
showing bilateral pulmonary nodules; a CT scan of his chest and abdomen showed 
extensive pulmonary nodules and moderate splenomegaly. The patient was started 
on empiric antibiotics for presumed pneumonia with concerns of sepsis. 
  
An exhaustive approach for a possible malignant etiology of the patient’s 
lymphadenopathy was initiated on the second day of hospitalization.  A CT-guided 
lung biopsy and bone marrow biopsy were initially conducted which were negative 
for any abnormal cells. Additionally, a PET-CT, VATS procedure, and several more 
bone marrow biopsies were performed, without any explanation for his symptoms. 
An extensive rheumatologic work up only showed mild positivity for anti-
cardiolipin IgG and beta-2 glycoprotein 1 antibody IgA positivity. Infectious work up 
for Rickettsia, Histoplasmosis, Blastomycosis, Bartonella, Syphillis, Tuberculosis, 
Babesiosis, fungal, viral, and other potential infectious etiologies were unrevealing.  
Of interest, the patient had one AFB positive sample from his VATS procedure after 
two weeks, however this specimen was concluded to be non-correlative. All repeat 
AFB cultures and sputum analyses were negative.  His hospital course was 
prolonged and complicated by bouts of altered mental status, continuing fevers and 
worsening pancytopenia.  
 
Approximately three hospital re-admissions for sepsis-like syndrome, a 
splenectomy was performed with pathology showing hemophagocytosis.  At the 
time of the splenectomy, an elevated ferritin value of > 70000 was noted, and 
fibrinogen levels were low. The patient was additionally found to have an elevated 
IL-2R. Thus, a diagnosis of HLH was made given pancytopenia, ferritin of 70000, 
elevated triglycerides, hypofibrinogenemia, elevated IL-2R, splenomegaly, 
hemophagocytosis on splenectomy and fevers. The patient was treated with 
etoposide and dexamethasone by his oncologist, per protocol, to which his 
cytopenia, ferritin and fibrinogen improved.  
 
Conclusion: 
HLH is a rare disease entity that is often confused for sepsis syndrome.  An extensive 
work up is urgent and necessary to adequately treat patients to reduce morbidity 
and mortality. 
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